Sotera Health Company (NASDAQ:SHC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $20.3333.

Several equities research analysts have weighed in on the company. Citigroup increased their target price on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Weiss Ratings lowered Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Barclays lowered their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 15.36% of the company’s stock.

Institutional Trading of Sotera Health

Institutional investors have recently modified their holdings of the company. Empowered Funds LLC grew its stake in shares of Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after purchasing an additional 43,471 shares during the period. Acadian Asset Management LLC grew its stake in Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after acquiring an additional 14,018 shares during the period. Creative Planning grew its stake in Sotera Health by 15.3% in the second quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after acquiring an additional 2,673 shares during the period. Finally, Invesco Ltd. grew its stake in Sotera Health by 4.2% in the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock valued at $3,549,000 after acquiring an additional 12,758 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Down 0.3%

Shares of SHC stock opened at $15.66 on Friday. The firm has a 50-day moving average price of $14.98 and a 200 day moving average price of $16.39. Sotera Health has a twelve month low of $10.80 and a twelve month high of $19.85. The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 38.20 and a beta of 1.82. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts forecast that Sotera Health will post 0.86 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.